Cargando…
Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
BACKGROUND: We used bleomycin, etoposide, cisplatin (BEP), the most effective regimen in the treatment of germ cell tumours (GCTs) and increased dose-density by using pegfilgrastim to shorten cycle length. Our aim was to assess safety and tolerability. METHODS: Sixteen male patients with intermediat...
Autores principales: | Rimmer, Y, Chester, J, Joffe, J, Stark, D, Shamash, J, Powles, T, White, J, Wason, J, Parashar, D, Armstrong, G, Mazhar, D, Williams, M V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171015/ https://www.ncbi.nlm.nih.gov/pubmed/21847130 http://dx.doi.org/10.1038/bjc.2011.309 |
Ejemplares similares
-
Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?
por: Addeo, A, et al.
Publicado: (2016) -
A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
por: Huddart, Robert A., et al.
Publicado: (2015) -
Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours
por: Lawrence, Nicola J., et al.
Publicado: (2018) -
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
por: Fosså, S D, et al.
Publicado: (2005) -
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
por: Peckham, M. J., et al.
Publicado: (1983)